Brief: Bone Therapeutics Secures 5 Million Euros Financing

Biosenic SA

12/04/2022 06:09

April 12 (Reuters) - Bone Therapeutics SA  BOTHE.BR :
    * SECURES EUR 5 MILLION FINANCING
    * PROCEEDS OF FINANCING WILL BE USED TO ADVANCE CLINICAL
DEVELOPMENT OF BONE THERAPEUTICS' LEAD ASSET, ALLOGENEIC BONE
CELL THERAPY, ALLOB.
    * BONE THERAPEUTICS AND ABO SECURITIES AIM TO AGREE ON AND
EXECUTE
THE FINAL SUBSCRIPTION AGREEMENT FOR THE CBS AND TO ISSUE THE
FIRST TRANCHE OF CBS BY THE BEGINNING OF MAY 2022
    * ISSUE AND SUBSCRIPTION OF REMAINING FIVE TRANCHES WITH A
PRINCIPAL AMOUNT OF EUR 500,000 EACH CAN BE DEMANDED AT BONE
THERAPEUTICS' SOLE DISCRETION OVER EIGHTEEN-MONTH PERIOD
    * A FIRST TRANCHE WITH AN AGGREGATE PRINCIPAL AMOUNT OF EUR
1.5 MILLION WILL BE ISSUED ON THE CLOSING DATE, FOLLOWED BY A
TRANCHE OF UP TO EUR 1 MILLION AFTER 40 TRADING DAYS FROM
CLOSING

Source text for Eikon:  ID:nGNE9hcvVt 
Further company coverage:  BOTHE.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))